Mounjaro (Tirzepatide) access in Cheshire and Merseyside (17th June 2025)
Access to Tirzepatide (Mounjaro) for Weight Loss
The new weight management ‘Tirzepatide’ medication (brand name Mounjaro®) is shortly being made available to NHS patients to support weight loss. The ICB (Integrated Care Board) are currently in the process of establishing new community-based weight management services, which are set to launch this summer. The ICB are working as quickly as possible to make these services available across Cheshire and Merseyside.
For further information on criteria / eligability, please copy and paste this address https://www.cheshireandmerseyside.nhs.uk/your-health/prescribing/statements/mounjaro-tirzepatide/ to your web browser.
Westbrook Medical Centre GP's and staff are unable to offer additional guidiance at this time. Thank you.
- Have a Body Mass Index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)
- Have at least four of the following long-term conditions:
1. Type 2 diabetes
2. Hypertension (high blood pressure)
3. Dyslipidaemia
4. Established cardiovascular disease
5. Obstructive sleep apnoea
However, this is not yet available in our area, below is a link to our ICB for more information:
https://www.cheshireandmerseyside.nhs.uk/your-health/prescribing/statements/mounjaro-tirzepatide/
💛 Help us understand cancer awareness! 💛
We’re running a short survey about signs and symptoms of cancer, focusing on womb (endometrial) and stomach (upper GI) cancer.
We want to know what people understand about these cancers so we can give the right information and support. It only takes a few minutes, and there are no right or wrong answers.
📋Take the survey here: Cancer Awareness Survey
Thank you for helping us improve cancer awareness in our community!
